References
- Wolf , H. G. 1963 . The pathphysiology of headache . Int. J Neurol. , 3 ( 1 ) : 287
- Lance , J. W . 1973 . Mechanism and Management of Headache , 2nd edn. London : Butterworth .
- Fozard , J. 1975 . The animal pharmacology of drugs in the treatment of migraine . J. Pharm. Pharmacol , 27 : 297 – 321 .
- Lance , J. W. 1991 . 5‐Hydroxytryptamine and its role in migraine . Eur. Neurol. , 31 ( 5 ) : 279 – 281 .
- Rabasseda , X. , Mealy , N. and Castaner , J. 1995 . Synthesis of MK‐0462 . Drugs of future , 20 ( 7 ) : 676 – 679 .
- Remuzon , P. , Dunny , C. , Jacquet , J. P. , Soumeillant , M. and Bouzard , D. 1995 . 4‐Hydroxy‐2‐methyl‐3(2H)‐isothiazolone‐1,1‐dioxide as protecting group of 4‐(N‐methylaminousulfonyl) methylphenylhydrazine during fischer indole synthesis . Tetrahedron Lett. , 36 ( 35 ) : 6227 – 6230 .
- Chen , C.‐Y. , Senanayake , C. H. , Billy , T. J. , Larsen , R. D. , Verhoeven , T. R. and Redider , P. J. 1994 . J.Org.Chem. , 59 : 3738
- Street , L. J. , Baker , R. , Davey , W. , Guiblin , A. R. , Jelly , R. A. , Reeve , A. J. , Routledge , H. , Sternfled , F. , Watt , A. P. , Beer , M. S. , Middlemiss , D. N , Noble , A. J. , Stanton , J. A. , Scholey , K. , Hargreaves , R. J , Sohal , B. , Graham , M. I. and Matassa , G. 1995 . Synthesis and serotonergic activity of N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethyamine and anologues. Potent agonists for 5-HT1D receptors . J. Med. chem. , 38 : 1799
- Baker , R. , Hadham , M. , Matassa , V. G. , Pelham , F. , Street , L. J. and Harlow . Triazole containing indole derivatives . US Patent. 5,298,520 . 1994 .
- Mallikarjuana , R. B. , Sangaraju , S. , Srinivasu , M. K , Madhavan , P. , Lalitha Devi , M. , Rajendrakumar , P. , Chandrasekhar , K. B , Arpita , Ch. and Satya Balaji , T. 2006 . Development of validation of a specific stability indicating high performance liquid chromatographic method for rizatriptan benzonate . J. Pharm. Biomed. Anal. , 41 : 1146 – 1152 .
- ICH Guidelines, Q3A (R) Impurities in New Drug Substances . 2002 . The quality guidelines for Active Pharmaceutical Ingredients related to impurities according to the International Conference of Horminization . February
- ICH Guidelines, Q3B (R) Impurities in New Drug Products . 2002 . The quality guidelines for Active Pharmaceutical Ingredients related to impurities according to the International Conference of Horminization . February